148 related articles for article (PubMed ID: 35229028)
1. UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis.
Huang ZF; Tang YL; Shen ZL; Yang KY; Gao K
Mol Ther Oncolytics; 2022 Mar; 24():497-506. PubMed ID: 35229028
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions.
Cheng T; Bai Y; Huang S; Wang Y; Zhou S; Liu H; Zhang R; Luo X; Yu P
J Gastrointest Oncol; 2022 Oct; 13(5):2485-2496. PubMed ID: 36388662
[TBL] [Abstract][Full Text] [Related]
3. miR-506 attenuates methylation of lncRNA
Wang XX; Guo GC; Qian XK; Dou DW; Zhang Z; Xu XD; Duan X; Pei XH
Cancer Cell Int; 2018; 18():171. PubMed ID: 30386180
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein.
Yang Z; Wang Z; Duan Y
Oncol Lett; 2020 Sep; 20(3):2183-2190. PubMed ID: 32782535
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
6. HOXD9 transcriptionally induced UXT facilitate breast cancer progression via epigenetic modification of RND3.
Hu XC; Chu J; Zhou Y; Li CC; Zhou GJ; Jiang GQ
Cell Signal; 2022 Feb; 90():110188. PubMed ID: 34767964
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
8. Maternally expressed 3 inhibits the biological activity of oral squamous cell carcinoma SCC25 and CAL27 cell lines.
Wang W; Li H; Qiu Y; Li K; Lu Y; Deng Q; Liu T
Oncol Lett; 2021 Nov; 22(5):784. PubMed ID: 34594425
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3-210 regulates endometrial stromal cells migration, invasion and apoptosis through p38 MAPK and PKA/SERCA2 signalling via interaction with Galectin-1 in endometriosis.
Liu Y; Ma J; Cui D; Fei X; Lv Y; Lin J
Mol Cell Endocrinol; 2020 Aug; 513():110870. PubMed ID: 32446846
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
11. DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation.
Zhu X; Lv L; Wang M; Fan C; Lu X; Jin M; Li S; Wang F
Cancer Cell Int; 2022 Feb; 22(1):56. PubMed ID: 35109842
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA MEG3 Modifies Cell-Cycle, Migration, Invasion, and Proliferation Through AKAP12 by Sponging miR-29c in Meningioma Cells.
Ding C; Yi X; Xu J; Huang Z; Bu X; Wang D; Ge H; Zhang G; Gu J; Kang D; Wu X
Front Oncol; 2020; 10():537763. PubMed ID: 33251130
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
17. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.
Sánchez-Morgan N; Kirsch KH; Trackman PC; Sonenshein GE
J Cell Biochem; 2017 Aug; 118(8):2347-2356. PubMed ID: 28106301
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis.
Wu L; Zhu L; Li Y; Zheng Z; Lin X; Yang C
Cancer Cell Int; 2020; 20():12. PubMed ID: 31938020
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis.
Zhao Y; Zhu Z; Shi S; Wang J; Li N
Biomed Pharmacother; 2019 Dec; 120():109457. PubMed ID: 31585300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
